EDITH HEINE: Open Payments
NPI 1376136887 · CHESAPEAKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,339 in 108 payments from 26 companies in 2025. Trend: 2023 $3,264 · 2024 $1,892 · 2025 $2,339
Food & beverage: $2,339
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 28 | $590 |
| AstraZeneca Pharmaceuticals LP | 12 | $238 |
| GENZYME CORPORATION | 8 | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $172 |
| JAZZ PHARMACEUTICALS INC. | 6 | $137 |
| Philips North America LLC | 5 | $102 |
| Regeneron Healthcare Solutions, Inc. | 5 | $97 |
| Baxter Healthcare | 4 | $92 |
| Mallinckrodt Hospital Products Inc. | 3 | $81 |
| Amgen Inc. | 4 | $75 |
Products named: NUCALA, DUPIXENT, TRELEGY ELLIPTA, XYWAV, FASENRA, OFEV, Hillrom - Vest System Model 105 Home Care, ACTHAR.
Industry payments across VA — which companies pay providers there.
